.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
McKinsey
Covington
Fish and Richardson
Queensland Health
Chubb
QuintilesIMS
Argus Health
Farmers Insurance

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021697

« Back to Dashboard
NDA 021697 describes VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER, which is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER profile page.

The generic ingredient in VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER is conivaptan hydrochloride. One supplier is listed for this compound. Additional details are available on the conivaptan hydrochloride profile page.

Summary for NDA: 021697

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 021697

Suppliers and Packaging for NDA: 021697

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VAPRISOL
conivaptan hydrochloride
INJECTABLE;IV (INFUSION) 021697 NDA Cumberland Pharmaceuticals Inc. 66220-160 66220-160-10 1 BAG in 1 BOX (66220-160-10) > 1 POUCH in 1 BAG > 100 mL in 1 POUCH
VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
conivaptan hydrochloride
INJECTABLE;IV (INFUSION) 021697 NDA Cumberland Pharmaceuticals Inc. 66220-160 66220-160-10 1 BAG in 1 BOX (66220-160-10) > 1 POUCH in 1 BAG > 100 mL in 1 POUCH

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;IV (INFUSION)Strength20MG/4ML (5MG/ML)
Approval Date:Dec 29, 2005TE:RLD:No
Patent:► SubscribePatent Expiration:Dec 15, 2019Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR INTRAVENOUS TREATMENT OF PATEINTS WITH EUVOLEMIC HYPONATREMIA
Patent:► SubscribePatent Expiration:Dec 15, 2019Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR INTRAVENOUS TREATMENT OF PATIENTS WITH HYPERVOLEMIC HYPONATREMIA

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;IV (INFUSION)Strength20MG/100ML (0.2MG/ML)
Approval Date:Oct 8, 2008TE:RLD:Yes
Patent:► SubscribePatent Expiration:Dec 15, 2019Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR INTRAVENOUS TREATMENT OF PATEINTS WITH EUVOLEMIC HYPONATREMIA


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Deloitte
Merck
Boehringer Ingelheim
Farmers Insurance
Mallinckrodt
Harvard Business School
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot